Owner Pierre Fabre Medicament

Inventors Goetsch, Liliane; Corvaia, Nathalie; Leger, Olivier

Agent Freehills

Pub. Number AU-B-2009201674

Parent 2003216748

Filing date 24 April 2009

Wipo publication date 21 May 2009

Acceptance publication date 16 August 2012

C07K 16/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A01K 67/027 Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

A61K 31/4035

A61K 31/415 - 1,2-Diazoles

A61K 31/517 - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/519 - ortho- or peri-condensed with heterocyclic rings

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 Medicinal preparations containing active ingredients not provided for in groups

A61P 17/06 Drugs for dermatological disorders

A61P 35/00 Antineoplastic agents

C07K 16/40 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

C12N 1/15 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 9/99 Enzymes, e.g. ligases (6.) - Enzyme inactivation by chemical treatment

C12N 15/09 Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/20 Mutation or genetic engineering

C12P 21/08 Preparation of peptides or proteins - Monoclonal antibodies

G01N 33/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay